← FDA Drug Approvals (Drugs@FDA)

IDOSE TR

NDA · New Drug Application · Sponsor: GLAUKOS · Approved 2023-12-13

Drug application

FDA Application #

NDA218010

Application type

New Drug Application

Brand name

IDOSE TR

Generic name

TRAVOPROST INTRACAMERAL

Active ingredients

TRAVOPROST

Dosage form

IMPLANT

Route

INTRACAMERAL

Marketing status

Prescription

Sponsor

GLAUKOS

Manufacturer

Glaukos Corporation

First approval

2023-12-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown